PRGO

Perrigo Company plc · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-07 19:17 UTC

Last close

15.83USD

Market data, 2026-11-04

PRGO: weekly closes from 14.44 on 2025-11-07 to 15.83 on 2026-11-04, a move of +9.6%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-04

Over that span: +9.6%

Except where said otherwise: 10-K for 2025, filed 2026-02-26

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
-33.5%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
3.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
1.30Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
7.3%Dividend yield
Source
computed
Taken on
2026-11-06
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-26

Growth is the furthest below its sector's middle: 0.11 against 0.50 on the market's range.

Five bars, one line

lens 7 of 9

0.95x

2.55x

0.44x

0.96x

0.35x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales0.95x
Its own average over 10 years, 4.48B.
Profit2.55x
Its own average over 10 years, -559.8M.
Free cash flow0.44x
Its own average over 10 years, 327.4M.
Debt0.96x
Its own average over 10 years, 3.98B.
Price0.35x
Its own average over 11 years, 45. Market data, 2026-11-04

Profit is furthest from its own average, at 2.55 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	100.0
2017-12-31	93.7	99.5
2018-12-31	89.6	96.5
2019-12-31	73.3	95.3
2020-12-31	77.4	95.7
2021-12-31	78.4	93.2
2022-12-31	84.3	93.9
2023-12-31	88.2	94.4
2024-12-31	82.8	95.9
2025-12-31	80.5	96.7

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001585364-26-000009
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001585364-26-000009
Reported in: USD

The filing itself

Figures behind the shape

Growth

0.8%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate0.8%
Source
computed
Taken on
2026-11-06
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-06
Reported in
USD
- computed
One-year change in net income-729.7%
Source
computed
Taken on
2026-11-06
Reported in
USD
- computed

Returns on capital

-48.6%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
Return on equity-48.6%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
Return on assets-16.7%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself

Margins

35.1%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin35.1%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Operating margin-26.4%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Net margin-33.5%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Free cash flow margin3.4%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself

Price

0.8x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
Price to book0.8x10-Q for 2025, filed 2026-08-05
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001585364-26-000145
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-05
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-02-26
The filing itself
Price to sales ratio0.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself

Safety

1.30

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equity1.30
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
Current ratio2.7610-Q for 2025, filed 2026-08-05
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001585364-26-000145
Reported in
USD
- 10-Q for 2025, filed 2026-08-05
- 10-Q for 2025, filed 2026-08-05
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Altman Z-Score-0.05
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-06
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26

What it pays out

7.3%

more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06

Dividend yield7.3%
Source
computed
Taken on
2026-11-06
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-26
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001585364-26-000009
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Dividend cover ratio0.9x
Source
computed
Taken on
2026-11-06
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.